Q4 fiscal 2026 Management View "Total revenues for the year were $149 million" and Elite delivered "operating income was $49 million" while "operating cash flow this year was positive $23.7 million," ...

Elite Pharmaceuticals, Inc. ELTP reported breakeven earnings per share in the first quarter of fiscal 2025, flat year over year. Elite Pharmaceuticals registered revenues of $18.8 million in the ...

ELTP delivers record fiscal 2026 results, with stronger profits, improved cash and pipeline progress supporting its expanding ...

Financials for Fiscal Year 2026 Ended March 31, 2026 will be released on Monday, June 29, 2026Northvale, New ...

About Elite Pharmaceuticals, Inc.Elite Pharmaceuticals, Inc. is a specialty pharmaceutical company that develops and distributes niche generic products. Elite specializes in developing and ...

Northvale, New Jersey--(Newsfile Corp. - April 30, 2025) - Elite Pharmaceuticals, Inc. (ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, today ...

Conference Call Scheduled for Friday, November 15 at 11:30 AM EST Northvale, New Jersey--(Newsfile Corp. - November 14, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a ...

June 29, 2026) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company developing niche generic products, announced results for the fiscal year ended ...

Good morning, ladies and gentlemen, and welcome to the Elite Pharmaceuticals Year-End Fiscal Year 2026 Conference Call. [Operator Instructions]. Before management begins speaking, the conference has ...

Analyze the earnings history of ELITE PHARMS INC by Elite Pharmaceuticals, Inc. using advanced sorting and filters. The chart below shows ELITE PHARMS INC by Elite Pharmaceuticals, Inc.'s reported EPS ...